Synedgen Raises $2.6M
socalTECH
JANUARY 30, 2020
Claremont-based Synedgen , a biotechnology company developing wound care technology, said this morning that it has raised $2.6M in funding. Source of the funding was not announced. According to the company, the funding will go towards commercialization of two, U. S. Food and Drug Administration (FDA) 510(k)-cleared products for wound care. The comopany says it is using glycochemistry for development of its drugs, which it says enhance and mimic the innate immune system.
Let's personalize your content